Canio J. Marasco
University of North Carolina at Chapel Hill
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Canio J. Marasco.
Biochemical and Biophysical Research Communications | 1988
Larry W. Daniel; George W. Small; Jeffrey Daniel Schmitt; Canio J. Marasco; Khalid S. Ishaq; Claude Piantadosi
Alkylacylglycerols are synthesized when choline-phospholipids are degraded by a phospholipase C. This class of compounds has been shown to have biological activities; however, the mechanism of action is unknown. A series of alkyl-linked diglycerides were synthesized and tested for activity in an in vitro assay for protein kinase C. When protein kinase C activity was stimulated with the synthetic diacylglyceride analog 1-oleoyl-2-acetyl-sn-glycerol, the addition of alkyl glycerides caused a concentration-dependent inhibition of protein kinase C activity. Comparison of the protein kinase C inhibition by this series of 1-O-alkyl-2-acyl analogs revealed that both saturated and unsaturated long-chain groups in position 1 were effective and that dietherglycerols with short-chain moieties in position 2 were also effective. It is concluded from these studies that the biological activity of alkyl-linked glycerides may be expressed through protein kinase C inhibition.
Antimicrobial Agents and Chemotherapy | 2008
Janice R. Sufrin; Arthur J. Spiess; Canio J. Marasco; Donna Rattendi; Cyrus J. Bacchi
ABSTRACT The purine nucleoside 5′-deoxy-5′-(hydroxyethylthio)-adenosine (HETA) is an analog of the polyamine pathway metabolite 5′-deoxy-5′-(methylthio)-adenosine (MTA). HETA is a lead structure for the ongoing development of selectively targeted trypanocidal agents. Thirteen novel HETA analogs were synthesized and examined for their in vitro trypanocidal activities against bloodstream forms of Trypanosoma brucei brucei LAB 110 EATRO and at least one drug-resistant Trypanosoma brucei rhodesiense clinical isolate. New compounds were also assessed in a cell-free assay for their activities as substrates of trypanosome MTA phosphorylase. The most potent analog in this group was 5′-deoxy-5′-(hydroxyethylthio)-tubercidin, whose in vitro cytotoxicity (50% inhibitory concentration [IC50], 10 nM) is 45 times greater than that of HETA (IC50, 450 nM) against pentamidine-resistant clinical isolate KETRI 269. Structure-activity analyses indicate that the enzymatic cleavage of HETA analogs by trypanosome MTA phosphorylase is not an absolute requirement for trypanocidal activity. This suggests that additional biochemical mechanisms are associated with the trypanocidal effects of HETA and its analogs.
Journal of Medicinal Chemistry | 1991
Claude Piantadosi; Canio J. Marasco; Susan L. Morris-Natschke; Karen L. Meyer; Fatma Gümüş; Jefferson R. Surles; Khalid S. Ishaq; Louis S. Kucera; Nathan Iyer; C. Anne Wallen; Steven Piantadosi; Edward J. Modest
Archive | 1991
Claude Piantadosi; Canio J. Marasco; Louis S. Kucera
Journal of Medicinal Chemistry | 1990
Canio J. Marasco; Claude Piantadosi; Karen L. Meyer; Susan L. Morris-Natschke; Khalid S. Ishaq; George W. Small; Larry W. Daniel
Journal of Medicinal Chemistry | 2002
Canio J. Marasco; Debora L. Kramer; John H. Miller; Carl W. Porter; Cyrus J. Bacchi; Donna Rattendi; Louis S. Kucera; Nathan Iyer; Ralph J. Bernacki; Paula Pera; Janice R. Sufrin
Antimicrobial Agents and Chemotherapy | 1996
Janice R. Sufrin; Donna Rattendi; Arthur J. Spiess; S Lane; Canio J. Marasco; Cyrus J. Bacchi
Journal of Medicinal Chemistry | 1990
Susan L. Morris-Natschke; Karen L. Meyer; Canio J. Marasco; Claude Piantadosi; Fiona Rossi; Patrick L. Godwin; Edward J. Modest
Archive | 1996
Judith K. Christman; Canio J. Marasco; Gholamreza Sheikhnejad; Janice R. Sufrin
Cancer Research | 2015
Canio J. Marasco; Joseph A. Dunn; Paula Pera; Alexander E. Macubbin